Longevity Medicine
By Faisal Darwiche, NP — 2026-06-06
This is the question that decides whether the whole weight-loss-clinic idea is even open to you, and the honest answer has a "depends" in it that most pages skip. Whether an NP can prescribe semaglutide — the molecule sold as Ozempic and Wegovy — *independently* comes down to your state's practice-authority rules, not the drug. I'm an NP who prescribes these protocols; here's the clear version, without the hand-waving.
Yes — an NP with prescriptive authority can prescribe semaglutide and tirzepatide. Whether you can do it independently depends on your state. In full-practice-authority states, an NP can prescribe these on their own. In reduced- or restricted-practice states, prescribing requires a collaborative or supervisory agreement with a physician. The drug isn't the variable — your state's NP practice-authority law is. Confirm yours before you build anything around it.
*This is general educational guidance on scope, not legal advice. Verify your state's NP practice-authority and prescribing rules with your board and your own counsel.*
Yes — if an NP can prescribe semaglutide, an NP can prescribe Ozempic, because Ozempic *is* semaglutide. Ozempic and Wegovy are brand names for the same molecule; Ozempic is FDA-approved for type 2 diabetes and Wegovy for weight management, but the active drug is identical. So the brand on the pen doesn't change the scope answer — the same practice-authority rules apply. In a full-practice-authority state, an NP prescribes it independently. In a reduced- or restricted-practice state, it's done under a collaborative or supervisory agreement. What does change between brands is the *on-label indication* you're prescribing for and the insurance/coverage picture, not your authority to write the script.
It means you write the prescription under your own authority, with no required physician oversight on that decision. That's the picture in full-practice-authority states. In reduced-practice and restricted-practice states, your prescribing happens under a defined collaborative or supervisory arrangement — you may still do nearly all of the clinical work, but a physician relationship is part of the legal structure. So "can an NP prescribe semaglutide?" is almost always yes; "can an NP prescribe it with zero physician involvement?" is the question your state answers.
Look up two things: your state's NP practice-authority category (full, reduced, or restricted) and any controlled-substance or specific prescribing rules that layer on top. GLP-1 medications aren't controlled substances, which simplifies it — but the practice-authority category still governs whether a collaborative agreement is required. Your state board of nursing is the source of truth. Don't take a course's or a vendor's word for your scope; verify it directly.
No — an RN can't prescribe GLP-1 medications. An RN can administer an injection that a prescriber has ordered, and RNs do that in all 50 states. But selecting the patient, writing the prescription, and owning the protocol is prescribing, which sits outside an independent RN scope everywhere. An RN who wants to run a weight-loss program needs a prescriber — NP, PA, or physician — to make and own those clinical decisions.
Yes — plenty of strong weight-loss and longevity practices run in reduced- and restricted-practice states. You structure a compliant collaborative or supervisory agreement, define who's responsible for what, and build from there. The agreement is a structure to set up correctly, not a wall. The clinics that get into trouble aren't the ones with collaboration requirements — they're the ones that ignored the requirement and prescribed outside their lawful scope.
It means the prescribing question is the first gate, not the last. If you're an NP in a full-practice-authority state, the lane is wide open. If you're in a collaborative state, the lane is open too — you just build the prescriber relationship into the structure from day one. Either way, get this settled before you spend on branding or a lease. For the full clinic build, see how to start a GLP-1 weight-loss clinic.
*Outcomes, demand, and income vary by market, model, and operator. Nothing here is a promise of results.*
In full-practice-authority states, yes — an NP can prescribe semaglutide under their own authority. In reduced- or restricted-practice states, prescribing requires a collaborative or supervisory physician agreement. The variable is your state's NP practice-authority category. Confirm with your board.
Yes — Ozempic is the brand name for semaglutide, so the same scope answer applies. An NP with prescriptive authority can prescribe it: independently in a full-practice-authority state, or under a collaborative or supervisory agreement in a reduced- or restricted-practice state. Wegovy is the same molecule branded for weight management. The brand doesn't change your authority; your state's practice-authority category does.
Yes — the same rules that apply to semaglutide apply to tirzepatide. An NP with prescriptive authority can prescribe it; whether independently or under collaboration depends on your state's practice-authority category. Neither is a controlled substance, which simplifies the prescribing picture.
No. An RN can administer an ordered injection but can't prescribe GLP-1s or own the clinical protocol — that's prescribing, which is outside an independent RN scope. An RN-led program needs a prescriber (NP, PA, or physician) to make those decisions.
Only if your state is a reduced- or restricted-practice state. Full-practice-authority states don't require one for NP prescribing. Check your state board's practice-authority category to know which applies to you.
No — semaglutide and tirzepatide aren't controlled substances, so DEA scheduling rules don't add a layer here. Your NP practice-authority category still governs whether you prescribe independently or under collaboration. Always verify current rules with your board.
The free 17-question assessment returns a state-specific 90-day launch plan: scope, entity, supplier sequence, and the exact next action for your scenario. 7 minutes. No card. Built by Faisal Darwiche, NP.
About the author
Faisal Darwiche, NP, is the founder of My Practice Academy. He's an AANP-certified nurse practitioner (MSN, adult-gerontology primary care) with 27+ years of clinical experience, a key opinion leader for leading aesthetic device companies, and faculty at The Aesthetic Show. He prescribes and runs longevity and weight-management protocols in his own practices, has built and sold an aesthetics practice, and currently operates three. This article is general educational guidance, not legal or medical advice; confirm prescribing, scope-of-practice, and supervision requirements with your state board and your own counsel.